No menu items!
Friday, June 5, 2026

Cancer Research Program

DBT-NII Receives Trademark for India’s First Indigenous Tumour Antigen SPAG9

ASPAGNIITM is being used in dendritic cell (DC) based immunotherapy in cervical, ovarian cancer and will also be used in breast cancer. ASPAGNIITM may revolutionise cancer treatment Cancer kills 8.51 lakh people in India every year (International Agency for Research on...
- Advertisement -spot_img

Latest News

Zourney.in Bets on AI To Simplify India’s B2B Travel

India’s B2B travel market is still shaped by fragmented systems, manual coordination and slow turnaround times for agents. Sandeep...
- Advertisement -spot_img